Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · Real-Time Price · USD
4.160
-0.270 (-6.09%)
At close: Nov 12, 2026, 4:00 PM EST
4.720
+0.560 (13.46%)
After-hours: Nov 12, 2026, 7:50 PM EST
Relmada Therapeutics Market Cap
Relmada Therapeutics has a market cap or net worth of $443.75 million as of November 12, 2026. It is the 15,256th most valuable company in the world and the 2,798th biggest in the United States. Its market cap has increased by 306.36% in one year.
Market Cap
443.75M
Enterprise Value
241.62M
1-Year Change
306.36%
Global Rank
Country Rank
#2,798 United States
Category
ChartMarket Cap Chart
Since September 30, 2015, Relmada Therapeutics's market cap has increased from $56.60M to $443.75M, an increase of 684.00%. That is a compound annual growth rate of 20.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 443.75M | 25.28% |
| Dec 31, 2025 | 354.20M | 2,156.05% |
| Dec 31, 2024 | 15.70M | -87.40% |
| Dec 29, 2023 | 124.60M | 18.67% |
| Dec 30, 2022 | 105.00M | -73.42% |
| Dec 31, 2021 | 395.00M | -24.17% |
| Dec 31, 2020 | 520.90M | 30.00% |
| Dec 31, 2019 | 400.70M | 1,125.38% |
| Dec 31, 2018 | 32.70M | 247.87% |
| Dec 29, 2017 | 9.40M | -28.24% |
| Dec 30, 2016 | 13.10M | -54.67% |
| Dec 31, 2015 | 28.90M | -48.94% |
| Sep 30, 2015 | 56.60M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Indaptus Therapeutics | 493.00M |
| Avalo Therapeutics | 492.07M |
| MiMedx Group | 484.47M |
| Monopar Therapeutics | 481.46M |
| Orchestra BioMed Holdings | 473.02M |
| Oculis Holding AG | 469.78M |
| Gyre Therapeutics | 466.26M |
| CytomX Therapeutics | 464.35M |